BIOCat. No. 3194 |
Price and AvailabilityBy clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy. |
|
Alternative Name: 6BIO Chemical Name: (2'Z,3'E)-6-Bromoindirubin-3'-oxime |
Biological Activity
Potent and selective, ATP-competitive glycogen synthase kinase-3 (GSK-3) inhibitor (IC50 values are 5, 83, 300, 320 and > 10 000 nM at GSK-3, CDK5/p25, CDK2/cyclin A, CDK1/cyclin B and other common kinases respectively). Maintains self-renewal and pluripotency in embryonic stem cells via activation of the Wnt signaling pathway in vitro; also promotes proliferation and dedifferentiation in cardiomyocytes.Certificate of Analysis / Safety Data Sheet
References
Meijer et al (2003) GSK-3-selective inhibitors derived from tyrian purple indirubins. Chem.Biol. 10 1255. PMID: 14700633.
Polychronopoulos et al (2004) Structural basis for the synthesis of indirubins as potent and selective inhibtors of glycogen synthase kinase-3 and cyclin dependent kinases. J.Med.Chem. 47 935. PMID: 14761195.
Tseng et al (2006) The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem.Biol. 13 957. PMID: 16984885.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: BIO, supplier, Potent, selective, GSK-3, inhibitors, Glycogen, Synthase, Kinases, 3, Carbohydrate, Metabolism, stem, cells
Quick Order
Find multiple products by catalog number
New Products in this Area
Inhibitor of SCD1; selectively eliminates undifferentiated hPSCs from culture
KY 02111Promotes differentiation of human ESCs and iPSCs into cardiomyocytes
IQ 1Enables Wnt/β-catenin-driven expansion of ESCs; prevents spontaneous differentiation
Tocris Events
Win a Kindle
June 15 - 18, 2013
San Francisco, CA
Booth Number: 1032




